{"id":49310,"date":"2022-10-07T09:01:55","date_gmt":"2022-10-07T07:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/"},"modified":"2022-10-07T09:01:55","modified_gmt":"2022-10-07T07:01:55","slug":"labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/","title":{"rendered":"LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA\u2122"},"content":{"rendered":"
\n

\nInnovate UK, part of UK Research and Innovation (UKRI), has awarded LabGenius with a SMART grant to accelerate the development of its immune cell engager lead optimization capability<\/i>\n<\/p>\n

LONDON–(BUSINESS WIRE)–#AI<\/a>–LabGenius, a pioneer in the use of machine learning (ML) for antibody engineering, today announced that it has been awarded a highly competitive SMART grant from Innovate UK<\/a>. Grants from the \u00a325 million fund allow businesses like LabGenius to realize the potential of new ideas by investing in game-changing, commercially viable research and development projects.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nTo date, LabGenius\u2019 EVA<\/i><\/b> platform has been used to co-optimize mono- and multi-specific single domain antibodies for biochemical and bio functional properties, including stability, potency and selective tumor cell killing. This grant will be used to further expand EVA<\/i><\/b>‘<\/i>s capabilities <\/i>by accelerating the platform\u2019s ability to optimize antibody-based immune cell engager molecules.\n<\/p>\n

\nMany existing antibody therapeutics have poor selective cell killing profiles, which can result in on-target, off-tumor effects, and the discontinuation of treatment. Using EVA<\/i><\/b>‘<\/i>s <\/i>predictive power, LabGenius is identifying non-intuitive protein designs, which perform well across multiple therapeutically valuable properties, including selective killing.\n<\/p>\n

\nCommenting on LabGenius\u2019 funding allocation, UKRI Board Member, Lord David Willetts said: \u201cMachine learning presents real promise to transform the way we approach cancer detection and treatment. It is incredibly exciting to see LabGenius focusing its efforts in this area of therapeutic innovation by continuing to advance their immune cell engager lead optimization capability.\u201d<\/i>\n<\/p>\n

\n\u201cWe\u2019re incredibly proud to have been awarded a SMART grant from Innovate UK\u201d <\/i>says LabGenius\u2019 CEO and Founder, Dr. James Field<\/a>. \u201cThis funding will help us realize the potential of computational technologies in R&D as we believe that they are the key to accelerating the discovery and development of advanced therapeutics.\u201d<\/i>\n<\/p>\n

\nSpeaking to the company\u2019s recent success, LabGenius\u2019 Chief Scientific Officer, Dr. Gino Van Heeke<\/a> said, \u201cLead optimization is a critical part of the antibody discovery process, and this funding will allow us to further demonstrate our platform\u2019s potential to use machine learning to accelerate the development of molecules with best-in-class properties.\u201d<\/i>\n<\/p>\n

\n\u2013 end \u2013<\/b>\n<\/p>\n

\nAbout LabGenius
\n
<\/b>Headquartered in London, LabGenius is a leading machine learning-driven protein engineering company. The company\u2019s core technology platform, EVA\u2122<\/i><\/b>, enables the rapid discovery of novel therapeutic antibodies. LabGenius\u2019 highly multidisciplinary team brings together the very best minds from the fields of computer science, robotic automation and synthetic biology.\n<\/p>\n

\nFor more information, please visit www.labgeni.us<\/a>, or connect on Twitter<\/a>, LinkedIn<\/a> and Medium<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor media enquiries, please contact Lucy Shaw<\/a> at press@labgeni.us<\/a>
For business development, please contact James Field<\/a> at partnerships@labgeni.us<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Innovate UK, part of UK Research and Innovation (UKRI), has awarded LabGenius with a SMART grant to accelerate the development of its immune cell engager lead optimization capability LONDON–(BUSINESS WIRE)–#AI–LabGenius, a pioneer in the use of machine learning (ML) for antibody engineering, today announced that it has been awarded a highly competitive SMART grant from … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49310","6":"format-standard","7":"category-industry"},"yoast_head":"\nLabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA\u2122 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA\u2122 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Innovate UK, part of UK Research and Innovation (UKRI), has awarded LabGenius with a SMART grant to accelerate the development of its immune cell engager lead optimization capability LONDON–(BUSINESS WIRE)–#AI–LabGenius, a pioneer in the use of machine learning (ML) for antibody engineering, today announced that it has been awarded a highly competitive SMART grant from ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-07T07:01:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221007005023\/en\/1592875\/21\/LabGenius_MoA_subs.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA\u2122\",\"datePublished\":\"2022-10-07T07:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\\\/\"},\"wordCount\":446,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005023\\\/en\\\/1592875\\\/21\\\/LabGenius_MoA_subs.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\\\/\",\"name\":\"LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA\u2122 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005023\\\/en\\\/1592875\\\/21\\\/LabGenius_MoA_subs.jpg\",\"datePublished\":\"2022-10-07T07:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005023\\\/en\\\/1592875\\\/21\\\/LabGenius_MoA_subs.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221007005023\\\/en\\\/1592875\\\/21\\\/LabGenius_MoA_subs.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA\u2122\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA\u2122 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/","og_locale":"en_US","og_type":"article","og_title":"LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA\u2122 - Pharma Trend","og_description":"Innovate UK, part of UK Research and Innovation (UKRI), has awarded LabGenius with a SMART grant to accelerate the development of its immune cell engager lead optimization capability LONDON–(BUSINESS WIRE)–#AI–LabGenius, a pioneer in the use of machine learning (ML) for antibody engineering, today announced that it has been awarded a highly competitive SMART grant from ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-07T07:01:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221007005023\/en\/1592875\/21\/LabGenius_MoA_subs.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA\u2122","datePublished":"2022-10-07T07:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/"},"wordCount":446,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221007005023\/en\/1592875\/21\/LabGenius_MoA_subs.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/","url":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/","name":"LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA\u2122 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221007005023\/en\/1592875\/21\/LabGenius_MoA_subs.jpg","datePublished":"2022-10-07T07:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221007005023\/en\/1592875\/21\/LabGenius_MoA_subs.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221007005023\/en\/1592875\/21\/LabGenius_MoA_subs.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA\u2122"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49310","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49310"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49310\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}